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Background: Mutations in the POU3F4 gene cause X-linked deafness type 3 (DFN3), which is characterized by
inner ear anomalies.
Methods: Three Turkish, one Ecuadorian, and one Nigerian families were included based on either inner ear
anomalies detected in probands or X-linked family histories. Exome sequencing and/or Sanger sequencing were
performed in order to identify the causative DNA variants in these families.
Results: Four novel, c.707A>C (p.(Glu236Ala)), c.772delG (p.(Glu258ArgfsX30)), c.902C>T (p.(Pro301Leu)), c.987T>C
(p.(Ile308Thr)), and one previously reported mutation c.346delG (p.(Ala116ProfsX26)) in POU3F4, were identified.
All mutations identified are predicted to affect the POU-specific or POU homeo domains of the protein and
co-segregated with deafness in all families.
Conclusions: Expanding the spectrum of POU3F4 mutations in different populations along with their associated
phenotypes provides better understanding of their clinical importance and will be helpful in clinical evaluation and
counseling of the affected individuals.
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Hearing loss is the most common sensory deficit with a
prevalence of approximately 1 in 1000 newborns [1].
Genetic factors account for at least 50% of cases with
congenital or prelingual-onset hearing loss in developed
countries. Among the genetic forms, previous studies
have indicated that deafness is transmitted with an
inheritance pattern consistent with autosomal recessive
in 75-77%, autosomal dominant in 15-20%, and X-linked
in 2-3% of cases [2,3]. To date, five loci (DFNX1-4, and
6) and four genes, PRPS1 (MIM 311850) for DFNX1 [4],
POU3F4 (MIM 300039) for DFNX2 [5], SMPX (MIM
300226) for DFNX4 [6,7], and COL4A6 (MIM 303631)* Correspondence: mtekin@med.miami.edu
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unless otherwise stated.for DFNX6 have been identified for X-linked hearing
loss [8].
DFNX2 (also referred to as Nance deafness) was
originally described by Nance et al. in 1971 as an X-linked
condition characterized in males by profound mixed
deafness, vestibular abnormalities and congenital fixation
at the stapes with perilymphatic gusher [9]. Computerized
tomography studies in patients with DFNX2 showed
abnormal dilatation of the internal acoustic canal and
abnormal communication between the internal acoustic
canal and inner ear compartments. Subsequently molecular
analysis revealed mutations in POU3F4 (POU domain, class
III, transcription factor 4- NM_000307.4) [10].
POU3F4 belongs to a superfamily of POU domain
transcription factors comprised of a POU-specific domain
and a POU-homeodomain, both of which influence DNA
binding and specificity. Previous studies showed that
the POU-specific part of the protein binds to DNA andl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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POU3F4 gene is expressed in the developing neural tube
during embryogenesis [11,12], and in a variety of other
organs including the inner ear [13-17]. Fifty two mutations
in POU3F4 have been reported as the cause of DFNX2
since the initial report (Additional file 1: Table S1) [18].
These variants include intragenic mutations and partial or
complete deletions of the gene, as well as chromosomal
deletions, inversions, and duplications [19]. Here we
report four novel and a previously reported mutations




This study was approved by the local Intitutional Review
Board at the University of Miami (USA), the Ethics
Commitee of Ankara University Medical School (Turkey),
Bioethics Committee of FFAA (HE-1) in Quito (Ecuador),
and the Joint Ethics Commitee of University of Ibadan/
University College Hospital Ibadan (Nigeria). A signed in-
formed consent form was obtained from each participant
or in the case of a minor, from parents. In addition
we obtained consent for publication of individual patient
data from all of the study participants.
Diagnosis of sensorineural hearing loss was established
via standard audiometry in a sound-proof room according
to current clinical standards. A physical examination was
performed on at least one hearing-impaired individual
from each family including a detailed clinical evaluation
and otoscopy. Affected individuals did not have delays in
gross motor development. Neither did they have balance
problems, vertigo, dizziness, or spontaneous and positional
nystagmus. Tandem walking was normal and Romberg test
was negative. Three Turkish families (295, 572, 667) were
included based on inner ear anomalies detected in pro-
bands. One Ecuadorian (1225) and one Nigerian (1535)
families were included based on X-linked family histories
and physical examination that was negative for additional
syndromic finding. Temporal bone CT scans were not
available in probands from Ecuador and Nigeria.
DNA Sequencing
Genomic DNA from total 5 affected and 8 unaffected
family members was extracted from peripheral blood
using standard methods. In probands from families 295,
572, 667, and 1535, the single exon of POU3F4 was
PCR-amplified and Sanger-sequenced. 20 ng of genomic
DNA were used for PCR amplification. PCR products
were purified by Qiagen MinElute PCR Purification Kit and
directly sequenced with a Beckman Coulter CEQ2000XL
or ABI 3730XL automated sequencers. In the proband of
family 1225, exome sequencing was performed via Illumina
HiSeq 2000 by using a previously published protocol [20].Segregation of the identified variants was evaluated in the
available family members of all families. DNA sequencing
data are stored in a secure internal database, which are
available upon request to researchers wishing to use them
for research purposes only.
Bioinformatics Analysis
For in silico analysis of the missense mutations,
PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/index.
shtml), SIFT (http://sift.jcvi.org/), and Mutation Taster
(http://www.mutationtaster.org/) were used for the pre-
diction of the effect of amino acid substitutions on protein
function. In addition 3D structures were modeled on the
Swiss-Model website (http://swissmodel.expasy.org) which
generates modeling for the target protein based on a
sequence alignment between the target protein and a
suitable template structure. These models were visual-
ized and delineated with RasMol (v. 2.7.5) software
(http://rasmol.org/).
Results and discussion
Five different POU3F4 mutations were detected in the
families (Table 1 and Additional file 2: Figure S1, S2, S3,
S4 and S5). Detected variants co-segregated with hearing
loss in all families. All four novel mutations were predicted
to affect the POU domains of the protein. The novel
NM_000307.4:c.772delG (p.(Glu258ArgfsX30)) mutation
truncates the protein within POU-specific domain. Simi-
larly, NM_000307.4:c.346delG (p.(Ala116ProfsX26)), which
has been previously reported in a Korean family with
severe deafness [21], leads to a truncation that eliminates
both POU domains.
In silico analysis for the three missense mutations,
NM_000307.4:c.707A>C (p.(Glu236Ala)), c.902C>T
(p.(Pro301Leu)), c.987T>C (p.(Ile308Thr)), predicted the
effect of amino acid substitutions on protein function clas-
sified as pathogenic (PolyPhen-2: probably damaging; SIFT:
damaging; Mutation Taster: disease causing). Structural
analysis of the p.Glu236Ala mutation showed that the
wild-type glutamate residue has a possible stabilizing
relationship with the lysine residue (Lys202) residing
within the alpha helix across the glutamate. The p.
Glu236Ala mutation introduces a non-polar amino acid
(alanine) instead of an acidic residue and possibly
interferes with the stability between the secondary
structures of the protein (Figure 1A). Proline has a
distinctive cyclic structure, which provides a conformational
rigidity. For that reason, it can commonly be found at turns
in protein structures, as seen here in the POU homeodo-
main. In the p.Pro301Leu mutation, the structure of the
turn changes becoming shorter (Figure 1B). The wild-type
isoleucine at position 308 is part of an alpha-helix in the
POU homeodomain. The p.Ile308Thr mutation introduces
a threonine residue with a hydroxide group and, according
Table 1 Clinical and genetic information of the probands in the affected families
Family 295 Family 572 Family 667 Family 1225 Family 1535
Country origin Turkey Turkey Turkey Ecuador Nigeria
POU3F4 c.772delG c.346delG c.707A>C c.902C>T c.987T>C
Mutation p.(Glu258ArgfsX30) p.(Ala116Profsx26) p.(Glu236Ala) p.(Pro301Leu) p.(Ile308Thr)
Age of onset Congenital <5 years <5 years <5 years <5 years




Hearing loss type Sensorineural Sensorineural Sensorineural Mixed Mixed
Hearing loss severity Moderate to severe Severe Profound Severe Severe
Laterality Bilateral Bilateral Bilateral Bilateral Bilateral
Inner Ear Anomaly Basal turns of cochlea are incompletely
separated from IAC which was dilated





of IAC; modioli are absent
N/A N/A
Intervention Hearing aids Cochlear implant Hearing aids Hearing aids Hearing aids
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change in the arginine residue at 323 (Figure 1C). All
three missense mutations are located in the two POU
domains of the protein (Figure 1D). None of the
identified variants was present in the Exome Variant
Server (http://evs.gs.washington.edu/EVS/), 1000 Genomes,
dbSNP, Leiden Open Variation Database (LOVD), or
Deafness Variation Database (DVD). These variants
were also absent in our next-generation sequencing
database that contains data of more than 2000 samples
from different ethnicities including Turkish (>200), Latin
American (>200), and Nigeria (>100).Figure 1 In silico analysis and molecular modeling of the wild-type an
possibly interferes with the stability between the secondary structures of th
of the turn and the turn becomes shorter (B). The hydroxide group introdu
change in the Arginine residue at 323 (C). Schematic illustration of POU3F4The phenotype of Nance deafness occurs because of
the loss of function mutations in the POU3F4 gene,
which encodes a transcription factor consisting of two
highly conserved domains [22]. The 76-78 amino acids
that contain the POU-specific domain cooperate with
the POU-homedomain to enhance the binding affinity
and specificity of DNA binding [16]. Hemizygous males
and heterozygous females carrying POU3F4 mutations
present with different clinical features. The hearing loss
affects males with rapid progression to severe or profound
deafness within the prelingual period. Temporal bone CT
scans of males with POU3F4 mutations show inner eard mutant POU3F4 proteins. The p.Glu236Ala (p.E236A) mutation
e protein (A). The p.Pro301Leu (p.P301L) mutation affects the structure
ced by the p.Ile308Thr (p.I308T) mutation causes a conformational
protein labeled with the five mutations identified in this study (D).
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which is responsible for gusher during stapes surgery. The
female carriers of POU3F4 mutations usually show no or
slight hearing loss [23]. In this study only males were
affected while carrier females did not present with
any clinical findings. Affected males’ middle and inner
ear anomalies were within the expected spectrum.
POU3F4 gene product is localized in the nucleus and
has a critical role in inner ear morphogenesis. Recent
studies showed that POU3F4 mutations might cause a
shift of Pou3f4 nuclear localization to the cytoplasm
[24]. All mutations we identified affect a POU domain
suggesting that loss of DNA binding capability may be a
common pathological mechanism for function [21].
Conclusions
In the present study we conclude that mutations in
POU3F4 cause X-linked hearing loss in different popula-
tions. It is especially important that the Ecuadorian and
Nigerian families were studied solely based on their inher-
itance pattern and found to have mutations in POU3F4,
suggesting that it is a common cause of X-linked hearing
loss worldwide. We recommend that diagnostic molecular
laboratories prioritize developing a POU3F4 test that
would be offered even when the results of CT scans were
not available. Identification of a causative mutation for
deafness provides families with a chance to make informed
reproductive decisions.
Additional files
Additional file 1: Table S1. Reported POU3F4 mutations.
Additional file 2: Figure S1. Data of the Family 295. Chromatograms
showing wild type (1A), hemizygous NM_000307.4:c.772delG
(p.(Glu258ArgfsX30)) mutation in the affected male (1B) and c.772delG
(p.(Glu258ArgfsX30)) mutation in the female carrier (1C). The pedigree
contains two affected male siblings (1D). Figure S2. Data of the family
667. Chromatograms showing wild type (2A), hemizygous NM_000307.4:
c.707A>C (p.(Glu236Ala)) mutation in the affected male (2B) and
c.707A>C (p.(Glu236Ala)) mutation in the female carrier (2C). One affected
male was in the family (2D). Figure S3. Data of the family 572.
Chromatograms showing wild type (3A), hemizygous NM_000307.4:
c.346delG (p.(Ala116Profsx26)) mutation in the affected male (3B) and
c.346delG (p.(Ala116Profsx26)) mutation in the female carrier (3C). One
affected male was in the family (3D). Figure S4. Data of the family 1225.
Chromatograms showing wild type (4A), hemizygous NM_000307.4:
c.902C>T (p.(Pro301Leu)) mutation in the affected male (4B) and
c.902C>T (p.(Pro301Leu)) mutation in the female carrier (4C). The
pedigree contains five affected males and is consistent with X-linked recessive
inheritance (4D). Figure S5. Data of the family 1535. Chromatogram showing
hemizygous NM_000307.4:c.987T>C (p.(Ile308Thr)) mutation in the affected
male (5A). There are three affected males and the pedigree is consistent with
X-Linked recessive inheritance (5B).
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